Collaboration Details

Print  Close


Title of Collaborative Activity:

Inter-agency Council on Biomedical Imaging in Oncology (ICBIO)

Description of Collaborative Activity:

Organized by the Cancer Imaging Program of Division of Cancer Treatment and Diagnosis (DCTD), Interagency Council on Biomedical Imaging in Oncology (ICBIO) is a confidential informational meeting for entities, usually small companies, planning product development in cancer. The Interagency Council on Biomedical Imaging in Oncology brings together technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing imaging devices or technology.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:

1999

NIH Participating Institutes/Centers/Office of the Director:

NCI

HHS Agency Collaborators on this Activity:

AHRQ, CMS, FDA